ARTICLE | Company News
Atrix, Tulane University deal
January 29, 2001 8:00 AM UTC
Tulane granted ATRX an exclusive option to license its human growth hormone releasing peptide-1 (GHRP-1) for use in treating growth hormone disorders. ATRX will formulate the peptide in its Atrigel ex...